Lipoprotein Metabolism and Inflammation in Patients With Psoriasis

Ehrin J. Armstrong, James G. Krueger

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


Psoriasis is a chronic inflammatory disease associated with a variety of co-morbid conditions, including cardiovascular disease. Advancements in our understanding of the cellular and molecular mechanisms of psoriasis have led to a better understanding regarding its pathogenesis, which in turn has stimulated ongoing research to identify the underlying pathophysiology responsible for the increased risk of cardiovascular events associated with psoriasis. Although not yet fully elucidated, emerging evidence points to immune-mediated inflammation as a process that contributes to endothelial cell dysfunction, dyslipidemia, and atherosclerosis as key processes influencing cardiovascular disease in psoriasis. In particular, the dyslipidemia present in psoriasis may be associated with altered lipoprotein function and increased atherogenicity. Here, we review how the cytokine networks involved in lipoprotein metabolism and inflammation could impact on the cardiovascular disease risk for patients with psoriasis.

Original languageEnglish (US)
Pages (from-to)603-609
Number of pages7
JournalAmerican Journal of Cardiology
Issue number4
StatePublished - Aug 15 2016
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Lipoprotein Metabolism and Inflammation in Patients With Psoriasis'. Together they form a unique fingerprint.

Cite this